血液公司
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionRoyce Value Trust Inc
Latest Disclosed Ownership267,914 shares
Latest Disclosed Value $ 19,989,063
Royce Value Trust Inc reports 3.78% increase in ownership of HAE / Haemonetics Corporation

On August 15, 2025 - Royce Value Trust Inc filed a NPORT-P form disclosing ownership of 267,914 shares of Haemonetics Corporation (US:HAE) valued at $19,989,064 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 19, 2025 disclosing 258,154 shares of Haemonetics Corporation. This represents a change in shares of 3.78% during the quarter. The current value of the position is $19,096,910 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-15 2025-06-30 NP Haemonetics EC US4050241003 267,914 9,760 3.78 19,989 21.85 0.9979
2025-05-19 2025-03-31 NP Haemonetics EC US4050241003 258,154 10,564 4.27 16,406 -15.14 0.8915
2025-02-21 2024-12-31 NP Haemonetics EC US4050241003 247,590 -16,162 -6.13 19,332 -8.82 0.9674
2024-11-19 2024-09-30 NP Haemonetics EC US4050241003 263,752 6,879 2.68 21,200 -0.24 1.0493
2024-08-12 2024-06-30 NP Haemonetics EC US4050241003 256,873 -43,533 -14.49 21,251 -17.11 1.1139
2024-05-28 2024-03-31 NP Haemonetics EC US4050241003 300,406 97,339 47.93 25,640 47.66 1.3105
2024-02-20 2023-12-31 NP Haemonetics EC US4050241003 203,067 36,828 22.15 17,364 16.61 0.9316
2023-11-22 2023-09-30 NP Haemonetics EC US4050241003 166,239 9,277 5.91 14,892 11.43 0.8953
2023-08-09 2023-06-30 NP Haemonetics EC US4050241003 156,962 40,815 35.14 13,364 39.04 0.7621
2023-05-19 2023-03-31 NP Haemonetics EC US4050241003 116,147 16,540 16.61 9,611 22.68 0.5695
2023-02-21 2022-12-31 NP Haemonetics EC US4050241003 99,607 -510 -0.51 7,834 5.71 0.4880
2022-11-17 2022-09-30 NP Haemonetics EC US4050241003 100,117 14,217 16.55 7,412 32.39 0.5021
2022-08-16 2022-06-30 NP Haemonetics EC US4050241003 85,900 23,300 37.22 5,599 41.47 0.3540
2022-05-16 2022-03-31 NP Haemonetics EC US4050241003 62,600 -4,300 -6.43 3,958 11.53 0.2064
2022-02-24 2021-12-31 NP Haemonetics EC US4050241003 66,900 -31,700 -32.15 3,548 -49.02 0.1650
2021-11-22 2021-09-30 NP Haemonetics EC US4050241003 98,600 21,270 27.51 6,960 35.07 0.3344
2021-08-24 2021-06-30 NP Haemonetics EC US4050241003 77,330 2,330 3.11 5,153 -38.10 0.2378
2021-05-17 2021-03-31 NP Haemonetics EC US4050241003 75,000 -80,900 -51.89 8,326 -55.03 0.3986
2021-02-19 2020-12-31 NP Haemonetics EC US4050241003 155,900 17,100 12.32 18,513 52.87 0.9802
2020-11-24 2020-09-30 NP Haemonetics EC US4050241003 138,800 21,600 18.43 12,110 15.38 0.8016
2020-08-19 2020-06-30 NP Haemonetics EC US4050241003 117,200 44,900 62.10 10,496 45.68 0.7288
2020-05-27 2020-03-31 NP Haemonetics EC US4050241003 72,300 58,200 412.77 7,205 344.75 0.6438
2020-02-19 2019-12-31 NP Haemonetics EC 405024100 14,100 14,100 1,620 0.0995
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.